Ansell Ltd
Company Profile
Business description
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.
Contact
678 Victoria Street
Level 3
Richmond
MelbourneVIC3121
AUST: +61 392707222
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 June 2026
Employees
15,724
Ansell Ltd News & Analysis
stocks
ASX results reaction: WiseTech, Woolies, Sigma and more
stocks
ASX healthcare stocks shrug off new tariff threat
stocks
3 cheap ASX shares with sound balance sheets
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,910.90 | 10.50 | -0.12% |
| CAC 40 | 8,022.69 | 29.82 | -0.37% |
| DAX 40 | 24,130.14 | 32.51 | -0.13% |
| Dow JONES (US) | 48,057.75 | 497.46 | 1.05% |
| FTSE 100 | 9,655.53 | 13.52 | 0.14% |
| HKSE | 25,692.12 | 151.34 | 0.59% |
| NASDAQ | 23,654.15 | 77.67 | 0.33% |
| Nikkei 225 | 50,532.94 | 69.86 | -0.14% |
| NZX 50 Index | 13,385.26 | 14.20 | 0.11% |
| S&P 500 | 6,886.68 | 46.17 | 0.67% |
| S&P/ASX 200 | 8,622.70 | 8.80 | -0.10% |
| SSE Composite Index | 3,894.15 | 6.34 | -0.16% |